SCHEMBL2002889

SCHEMBL2002889

COc1cc(O)cc(OC)c1[NH]

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.61
MAPT P10636 1/20 0.61
PTGS2 P35354 6/20 0.52
ALOX5 P09917 5/20 0.52
MAOB P27338 1/20 0.50
TDP1 Q9NUW8 1/20 0.44
CYP1A1 P04798 1/20 0.41
PTGS1 P23219 1/20 0.41
SNCA P37840 1/20 0.40
TTR P02766 1/20 0.39
APP P05067 1/20 0.39
SYNJ2 O15056 1/20 0.39
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
PTPN1 P18031 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8064768 0.78 CYP3A4 (0.67) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL70379 0.78 ALOX5 (0.70) CYP3A4MAPTPTGS2ALOX5MAOB
Ethane SCHEMBL27660205 0.76 ALOX5 (0.67) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL320899 0.76 CYP3A4 (0.64) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL2093672 0.76 ALDH1A1 (0.53) CYP3A4MAPTTDP1CYP1A1CA1
Antiarol SCHEMBL210578 0.76 CYP3A4 (1.00) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL684396 0.75 ALOX5 (0.59) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL23757778 0.74 CYP3A4 (0.61) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL4615262 0.74 PTGS2 (0.64) CYP3A4MAPTPTGS2ALOX5MAOB
SCHEMBL4835929 0.74 CYP3A4 (0.61) CYP3A4MAPTPTGS2ALOX5MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2245031-B1 6,9-DISUBSTITUTED PURINE DERIVATIVES AND THEIR USE AS COSMETICS AND COSMETIC COMPOSITIONS INST OF EX BOTANY ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) 2014-02-26 EP disclosed
US-8575182-B2 6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions Institute of Experimental Botany, Academy of Sciences of the Czeck Republic (CZ) 2013-11-05 US disclosed
US-20110230503-A1 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions SZUCOVA LUCIE 2011-09-22 US disclosed
US-7960397-B2 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions INSTITUTE OF EXPERIMENTAL BOTANY, ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) 2011-06-14 US disclosed
US-20090170879-A1 6,9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions SZUCOVA LUCIE 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170879-A1 6,9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions P2RY6, UMPS, PNP CYP3A4 3342/4885MAPT 2860/4885PTGS2 939/4885
US-20110230503-A1 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions P2RY6, UMPS, PNP CYP3A4 3342/4885MAPT 2860/4885PTGS2 939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.